Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/9/2018
SIETES contiene 92557 citas

 
 
 1 a 20 de 1155 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. FDA approval of cenegermin marks three firsts in drug history . DIA Daily 2018:24 de agosto. [Ref.ID 102813]
2. Cita con resumen
Anónimo. Conjonctivites présumées bactériennes. Prescrire 2018;38:361-5. [Ref.ID 102660]
3.Enlace a cita original Cita con resumen
The Dry Eye Assessment and Management Study Research Group. n-3 fatty acid supplementation for the treatment of dry eye disease. N Engl J Med 2018;378:3 de mayo. [Ref.ID 102592]
4.Enlace a cita original Cita con resumen
Rabin JC, Karunathilake N, Patrizi K. Effects of milk vs dark chocolate consumption on visual acuity and contrast sensitivity within 2 hours. A randomized clinical trial. Jama Ophthalmol 2018;136:678-81. [Ref.ID 102572]
6.Enlace a cita original Cita con resumen
Uyhazi KE, Miano T, Pan W, VanderBeek BL. Association of novel oral antithrombotics with the risk of intraocular bleeding. Jama Ophthalmol 2017:14 de diciembre. [Ref.ID 102190]
7. Cita con resumen
Tricco AC, Thomas SM, Veroniki AA, Hamid JS, Cogo E, Strifler L, Khan PA, Robson R, Sibley KM, MacDonald H, Riva JJ, Thavorn K, Wilson C, Holroyd-Leduc J, Kerr GD, Feldman F, Majumdar SR, Jaglal SB, Hui W, Straus SE. Comparisons of interventions for preventing falls in older adults. A systematic review and meta-analysis. JAMA 2017;318:1687-99. [Ref.ID 102139]
8. Cita con resumen
Kao JC, Liao B, Markovic SN, Klein CJ, Naddaf E, Staff NP, Liewluck T, Hammack JE, Sandroni P, Finnes H, Mauermann ML. Neurological complications associated with anti-programmed death 1 (PD-1) antibodies. JAMA Neurology 2017:5 de septiembre. [Ref.ID 102058]
11. Cita con resumen
Anónimo. Ranibizumab, bévacizumab ou aflibercept par voie intravitréenne: thromboses. Prescrire 2017;37:509-11. [Ref.ID 102009]
12. Cita con resumen
Becker C, Jick SS, Meier CR. Selective serotonin reuptake inhibitors and cataract risk: a case-control analysis. Ophthalmology 2017;124:1. [Ref.ID 101923]
13. Cita con resumen
Liebmann JM, Cioffi GA. Nicking glaucoma with nicotinamide?. N Engl J Med 2017;376:2079-81. [Ref.ID 101597]
14. Cita con resumen
Anónimo. Aflibercept et néovascularisations liées à une myopie forte. Prescrire 2016;36:811-2. [Ref.ID 100949]
15. Cita con resumen
Anónimo. Topiramate, zonisamide: panilopsies. Prescrire 2016;36:666. [Ref.ID 100822]
16. Cita con resumen
Anónimo. Idébénone et neuropathie optique de Leber. Prescrire 2016;36:651-2. [Ref.ID 100817]
18. Cita con resumen
Anónimo. Main goal in clinical trial. DIA Daily 2016:6. [Ref.ID 100668]
20.Enlace a cita original Cita con resumen
Page II RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J, On behalf of the American Heart Association Clinical Pharmacology and Heart Failure and Trans- plantation Committees of the Council on Clini- cal Cardiology, Coun- cil on Cardiovascular Surgery and Anesthesia, Council on Cardio- vascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Drugs that may cause or exacerbate heart failure. A scientific statement from the American Heart Association. Circulation 2016;134:9 de agosto. [Ref.ID 100519]
Seleccionar todas
 
 1 a 20 de 1155 siguiente >>